Genetic modulation of the SERCA activity does not affect the Ca2+ leak from the cardiac sarcoplasmic reticulum

Cell Calcium

Volumn 55, Issue 1, 2014, Pages 17-23

  Morimoto, Satoshi ^a   Hongo, Kenichi ^a   Kusakari, Yoichiro ^a   Komukai, Kimiaki ^a   Kawai, Makoto ^a   O Uchi, Jin ^b   Nakayama, Hiroyuki ^c   Asahi, Michio ^d   Otsu, Kinya ^e   Yoshimura, Michihiro ^a   Kurihara, Satoshi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c OSAKA UNIVERSITY   (Japan)

^d OSAKA MEDICAL COLLEGE   (Japan)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Aequorin; Cardiac muscle; Excitation contraction coupling; Transgenic mouse

Indexed keywords

CALCIUM ION; REGULATOR PROTEIN; SARCOLIPIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; EXCITATION CONTRACTION COUPLING; GENETIC MODULATION; GENETIC REGULATION; HEART CONTRACTION; HEART HEMODYNAMICS; HEART MUSCLE CELL; IN VITRO STUDY; MOLECULAR DYNAMICS; MOUSE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOPLASMIC RETICULUM; TRANSGENIC MOUSE; UPREGULATION;

MUS; MUS MUSCULUS;

AEQUORIN; CA(2+) TRANSIENT; CARDIAC MUSCLE; EXCITATION-CONTRACTION COUPLING; TRANSGENIC MOUSE;

ANIMALS; CALCIUM; HEMODYNAMICS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, ANIMAL; MUSCLE PROTEINS; MYOCARDIAL CONTRACTION; MYOCARDIUM; PROTEOLIPIDS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; UP-REGULATION;

EID: 84896724996     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2013.10.005     Document Type: Article

References (42)

1. Bers D.M. Cardiac excitation-contraction coupling. Nature 2002, 415:198-205.
2. Fabiato A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am. J. Physiol. 1983, 245:C1-C14.
3. 2+ content in rat ventricular myocytes. J. Physiol. 2011, 589:4723-4729.
4. Marx S.O., Reiken S., Hisamatsu Y., et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 2000, 101:365-376.
5. 2+ leak in mouse heart. Biochem. Biophys. Res. Commun. 2009, 390:87-92.
6. Shah A.P., Siedlecka U., Gandhi A., et al. Genetic background affects function and intracellular calcium regulation of mouse hearts. Cardiovasc. Res. 2010, 87:683-693.
7. Ai X., Curran J.W., Shannon T.R., Bers D.M., Pogwizd S.M. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circ. Res. 2005, 97:1314-1322.
8. Brochet D.X., Yang D., Cheng H., Lederer W.J. Elementary calcium release events from the sarcoplasmic reticulum in the heart. Adv. Exp. Med. Biol. 2012, 740:499-509.
9. Farrell E.F., Antaramian A., Rueda A., Gómez A.M., Valdivia H.H. Sorcin inhibits calcium release and modulates excitation-contraction coupling in the heart. J. Biol. Chem. 2003, 278:34660-34666.
10. 2+ affinity mutant of SERCA2a attenuates in vivo pressure overload cardiac hypertrophy. FASEB J. 2003, 17:61-63.
11. 2+ ATPase (SERCA2a) activity and impairs cardiac function in mice. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:9199-9204.
12. Hirano S., Kusakari Y., O-Uchi J., et al. Intracellular mechanism of the negative inotropic effect induced by alpha1-adrenoceptor stimulation in mouse myocardium. J. Physiol. Sci. 2006, 56:297-304.
13. 2+ transients by beta- and muscarinic receptor stimulation in ferret myocardium. J. Physiol. 1993, 461:167-184.
14. Kawai M., Konishi M. Measurement of sarcoplasmic reticulum calcium content in skinned mammalian cardiac muscle. Cell Calcium 1994, 16:123-136.
15. Andersson K.B., Birkeland J.A., Finsen A.V., et al. Moderate heart dysfunction in mice with inducible cardiomyocyte-specific excision of the Serca2 gene. J. Mol. Cell. Cardiol. 2009, 47:180-187.
16. Arai M., Alpert N.R., MacLennan D.H., Barton P., Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ. Res. 1993, 72:463-469.
17. Hasenfuss G., Reinecke H., Studer R., et al. Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. Circ. Res. 1994, 75:434-442.
18. Schwinger R.H., Böhm M., Schmidt U., et al. Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 1995, 92:3220-3228.
19. Hobai I.A., O'Rourke B. Decreased sarcoplasmic reticulum calcium content is responsible for defective excitation-contraction coupling in canine heart failure. Circulation 2001, 103:1577-1584.
20. Piacentino V., Weber C.R., Chen X., et al. Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ. Res. 2003, 92:651-658.
21. Miyamoto M.I., del Monte F., Schmidt U., et al. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:793-798.
22. Kawase Y., Ly H.Q., Prunier F., et al. Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure. J. Am. Coll. Cardiol. 2008, 51:1112-1119.
23. Jaski B.E., Jessup M.L., Mancini D.M., et al. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. J. Card. Fail. 2009, 15:171-181.
24. Trafford A.W., Díaz M.E., Sibbring G.C., Eisner D.A. Modulation of CICR has no maintained effect on systolic Ca2+: simultaneous measurements of sarcoplasmic reticulum and sarcolemmal Ca2+ fluxes in rat ventricular myocytes. J. Physiol. 2000, 522:259-270.
25. Yano M., Ikeda Y., Matsuzaki M. Altered intracellular Ca2+ handling in heart failure. J. Clin. Invest. 2005, 115:556-564.
26. Wehrens X.H.T., Lehnart S.E., Marks A.R. Ryanodine receptor-targeted anti-arrhythmic therapy. Ann. N.Y. Acad. Sci. 2005, 1047:366-375.
27. Wehrens X.H.T., Lehnart S.E., Reiken S.R., Marks A.R. Ca2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circ. Res. 2004, 94:e61-e70.
28. Xiao B., Zhong G., Obayashi M., et al. Ser-2030, but not Ser-2808, is the major phosphorylation site in cardiac ryanodine receptors responding to protein kinase A activation upon β-adrenergic stimulation in normal and failing hearts. Biochem. J. 2006, 396:7-16.
29. Belevych A.E., Terentyev D., Terentyeva R., et al. The relationship between arrhythmogenesis and impaired contractility in heart failure: role of altered ryanodine receptor function. Cardiovasc. Res. 2011, 90:493-502.
30. Respress J.L., van Oort R.J., Li N., et al. Role of RyR2 phosphorylation at S2814 during heart failure progression. Circ. Res. 2012, 110:1474-1483.
31. Oestreich E.A., Malik S., Goonasekera S.A., et al. Epac and phospholipase Cepsilon regulate Ca2+ release in the heart by activation of protein kinase Cepsilon and calcium-calmodulin kinase II. J. Biol. Chem. 2009, 284:1514-1522.
32. Grimm M., Brown J.H. β-Adrenergic receptor signaling in the heart: role of CaMKII. J. Mol. Cell. Cardiol. 2010, 48:322-330.
33. Pereira L., Cheng H., Lao D.H., et al. Epac2 mediates cardiac β1-adrenergic-dependent sarcoplasmic reticulum Ca2+ leak and arrhythmia. Circulation 2013, 127:913-922.
34. Fischer T.H., Herting J., Tirilomis T., et al. Ca2+/calmodulin-dependent protein kinase II and protein kinase A differentially regulate sarcoplasmic reticulum Ca2+ leak in human cardiac pathology. Circulation 2013, 128:970-981.
35. Lyon A.R., Bannister M.L., Collins T.T., et al. SERCA2a gene transfer decreases sarcoplasmic reticulum calcium leak and reduces ventricular arrhythmias in a model of chronic heart failure. Circ. Arrhythm. Electrophysiol. 2011, 4:362-372.
36. Cutler M.J., Wan X., Plummer B.N., et al. Targeted sarcoplasmic reticulum Ca2+ ATPase 2a gene delivery to restore electrical stability in the failing heart. Circulation 2012, 126:2095-2104.
37. Jessup M., Greenberg B., Mancini D., et al. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation 2011, 124:304-313.
38. Wright N.T., Varney K.M., Ellis K.C., et al. The three-dimensional solution structure of Ca(2+)-bound S100A1 as determined by NMR spectroscopy. J. Mol. Biol. 2005, 353:410-426.
39. Rohde D., Ritterhoff J., Voelkers M., Katus H.A., Parker T.G., Most P. S100A1: a multifaceted therapeutic target in cardiovascular disease. J. Cardiovasc. Transl. Res. 2010, 3:525-537.
40. Rohde D., Brinks H., Ritterhoff J., Qui G., Ren S., Most P. S100A1 gene therapy for heart failure: a novel strategy on the verge of clinical trials. J. Mol. Cell. Cardiol. 2011, 50:777-784.
41. Yang Z., Steele D.S. Effects of cytosolic ATP on Ca(2+) sparks and SR Ca(2+) content in permeabilized cardiac myocytes. Circ. Res. 2001, 89:526-533.
42. Smith G.L., O'Neill S.C. A comparison of the effects of ATP and tetracaine on spontaneous Ca(2+) release from rat permeabilised cardiac myocytes. J. Physiol. 2001, 534:37-47.